real peptides FAQ

Request batch reservation from Real Peptides at study onset. We synthesize mazdutide in controlled lots and can allocate sequential batches from the same reagent stock and resin batch for multi-phase studies. This eliminates the batch-to-batch variability that invalidates longitudinal comparisons. If your baseline cohort received peptide from Batch A (98.4% purity) and your 6-month cohort receives Batch B (96.9% purity), you've introduced a confounding variable. Competitors rarely track batch lineage or offer reservation services, which is why large research institutions specify Real Peptides for studies requiring temporal consistency.

HPLC-only verification is insufficient for confirming peptide identity because chromatographic peaks don't distinguish between the target peptide and deletion sequences with similar hydrophobicity. Request mass spectrometry data showing the observed molecular weight matches the calculated weight within ±0.5 Da. If the supplier can't provide mass spec on request, assume structural verification wasn't performed—the product may be pure by HPLC but contain functionally inactive deletion sequences or substitution errors. Switch to a supplier who performs both HPLC and mass spec as standard quality control on every batch.

A molecular weight deviation of ±2 Da suggests either oxidation of methionine residues (adds 16 Da per oxidized methionine) or incomplete deprotection during synthesis (leaves protecting groups attached, typically adding 14–42 Da). Both errors compromise biological activity because they alter the peptide's three-dimensional structure and receptor binding affinity. If the deviation is consistent across multiple vials from the same batch, it's a synthesis error—not a storage issue. The peptide is structurally incorrect and unsuitable for use. Demand batch documentation showing intermediate mass spec results during synthesis to determine where the error occurred.

Incomplete dissolution indicates aggregated peptides—molecules that clumped together due to temperature abuse or improper lyophilization. Centrifuge the solution at 10,000 × g for 5 minutes and measure the pellet volume. If more than 5% of the peptide forms a pellet, the batch experienced quality failure during production or storage. Aggregated peptides can't be salvaged—attempting to increase concentration or adjust pH won't restore solubility because the structural damage is irreversible. Request a replacement batch and verify the supplier ships with temperature-monitoring labels that would have detected the storage failure.

Contact the supplier immediately and request mass spectrometry data showing what comprises the remaining 3.2%. HPLC purity below 98% can mean benign excipients or critical impurities like deletion sequences and oxidized residues. Real Peptides maintains minimum 98% purity because mazdutide's dual-receptor mechanism requires intact structural domains. A 2% impurity fraction containing truncated GIP-binding sequences eliminates half the compound's intended activity. Competitors offering 95–97% purity at lower cost are not providing equivalent product. You're paying less for a peptide that may not work.

Discard it and request replacement. Mazdutide stored above −20°C for unknown duration undergoes peptide bond hydrolysis and aggregation that visual inspection cannot detect. The powder looks identical whether viable or denatured. Real Peptides includes temperature excursion indicators (irreversible color-change strips) in every cold chain shipment specifically to avoid this scenario. If a competitor ships without temperature monitoring and the package sat in a distribution center at 25°C for 72 hours, you won't know until experimental results fail. At which point you've wasted time, reagents, and research funding on a structurally compromised peptide.

Request tandem MS/MS sequencing data from your supplier. Not just the HPLC chromatogram. MS/MS fragments the peptide and sequences each fragment independently, detecting substitution errors that HPLC cannot. If your supplier cannot provide MS/MS data, the peptide may contain sequence errors at functionally critical residues (positions 1–18 or 19–23 in LL-37) that maintain molecular weight but destroy bioactivity. Switch to a supplier that performs per-batch MS/MS verification, or send a sample to an independent contract lab for sequencing confirmation before investing more time troubleshooting assay conditions that aren't the problem.

Do not use it. Temperature excursions above 10°C cause irreversible aggregation and partial denaturation even in lyophilised powder. Contact your supplier immediately and request a replacement with verified cold-chain shipping. If the supplier won't replace it or claims 'brief temperature exposure doesn't matter,' that's a supplier you shouldn't reorder from. Real Peptides includes temperature data loggers in high-value shipments specifically to catch this. If the peptide exceeded safe temperature, we reship at no cost before you waste your experimental budget on degraded compound.

Assume the purity claim is unverified and consider sourcing from a supplier with transparent testing. Without independent HPLC-MS verification, you have no objective evidence that the vial contains glutathione at the labeled concentration or that the GSH:GSSG ratio supports biological activity. In-house testing and certificates of compliance are not substitutes. They lack the independence and analytical resolution required to detect peptide fragments, residual solvents, or oxidation products. Real Peptides provides batch-specific reports accessible via QR code; if your current supplier cannot or will not provide equivalent documentation, the product quality is speculative.

Request the testing methodology used to determine purity—specifically whether HPLC, mass spectrometry, or UV spectrophotometry was employed. UV methods cannot distinguish correctly sequenced peptides from truncated or racemized variants, making them unsuitable for purity verification. If the supplier cannot provide HPLC chromatograms or mass spec data confirming molecular weight within ±1 dalton of theoretical mass, the advertised purity is unverifiable. Real peptides AHK-Cu vs competitors quality is decided by methodology transparency: suppliers providing full analytical data are demonstrating actual purity, while those offering only summary percentages are making claims you cannot independently verify.

LL-37 is prone to oxidation at methionine residues (Met-1, Met-6) when stored in solution, especially at temperatures above −20°C. Store lyophilised (freeze-dried) peptide at −80°C in sealed vials with desiccant. Not in solution. And reconstitute only the volume you'll use within 48 hours. Once reconstituted in sterile water or buffer, aliquot immediately into single-use volumes and freeze at −80°C. Avoid repeated freeze-thaw cycles, which denature the alpha-helical structure required for receptor binding. If activity loss occurs despite proper storage, the issue is likely oxidation during synthesis or shipping. Request a certificate confirming methionine protection during SPPS (typically via trityl or acetamidomethyl protecting groups).

Ask for third-party purity verification, endotoxin testing results, and synthesis method documentation before ordering. Price differences this large usually reflect bulk synthesis without per-batch quality control, in-house COAs that can't be independently validated, or ambient-temperature shipping that degrades the peptide en route. A $200 peptide that fails your assay costs more than a $350 peptide that works. Factor in wasted reagents, lost cell culture time, and delayed publication timelines. We've worked with labs who switched to Real Peptides after three failed attempts with budget suppliers. The total cost (including wasted materials) exceeded what they would have paid for verified peptides from the start.

Request a replacement COA for your specific lot immediately. A COA without a matching lot number is not valid verification. It could be from a batch synthesized months earlier with different purity characteristics. Real Peptides provides lot-matched COAs with every order; if yours is missing or mismatched, that's a fulfillment error that must be corrected before using the peptide. Generic COAs are a common cost-cutting measure in the peptide industry and the single clearest sign that batch-specific testing isn't being performed.

Discard it immediately and contact the supplier. Glutathione is a white to off-white powder when pure. Yellow, brown, or grey discoloration indicates oxidation or contamination, and clumping suggests moisture exposure that accelerates degradation. Pharmaceutical-grade glutathione stored properly remains free-flowing powder; discoloration or clumping are visual indicators of compromised stability that no amount of reconstitution can reverse. Request batch-specific HPLC data and inspect the vial seal. If the rubber stopper shows gaps or the nitrogen seal was compromised, the product degraded before you opened it.

Send a sample to an independent analytical lab for HPLC and mass spectrometry testing. Universities with biochemistry departments often offer this as a fee-for-service. Request both purity determination (HPLC) and molecular weight confirmation (mass spec). If the independent result differs from the supplier's COA by more than 2%, the supplier's quality control process is unreliable. This is expensive (typically $300–600 per test), but it's the only way to verify supplier claims when reproducibility is critical.

Expect 40–60% degradation within six months and near-complete oxidation within a year. Glutathione's oxidative instability accelerates dramatically at ambient temperature. The thiol group on cysteine reacts with atmospheric oxygen to form disulfide bonds, converting GSH to GSSG at rates that double with every 10°C increase in storage temperature. Refrigeration at 2–8°C slows this reaction to <2% degradation per year, preserving potency across typical research timelines. If refrigeration isn't available, order smaller quantities and use within 30 days. Storing large batches at room temperature turns pharmaceutical-grade glutathione into expensive placebo.

Yes, critically. In vivo LL-37 administration requires endotoxin levels below 0.5 EU/mg (stricter than the 1 EU/mg standard for in vitro work) because even trace LPS triggers systemic immune responses that confound peptide effects. Additionally, sequence errors that reduce antimicrobial potency by 20% in vitro can eliminate therapeutic effect entirely in vivo, where peptide concentrations at infection sites are already marginal. Use only peptides with documented LAL endotoxin testing per batch and full MS/MS sequencing confirmation. Generic suppliers optimised for in vitro research often lack the endotoxin control required for animal studies. Verify before purchasing.

Verify your peptide's actual purity via third-party HPLC analysis—request a chromatogram, not just a summary percentage. If deletion sequences exceed 2% or TFA residuals are above 0.2%, the peptide's biological activity is compromised regardless of advertised purity. Published studies typically use research-grade peptides with >99% verified purity and <0.1% contaminants; replicating those results with 95–96% commercial-grade peptide requires 30–50% higher concentrations, which can introduce off-target effects or exceed solubility limits. Switch to a supplier providing ISO-accredited third-party verification before adjusting your experimental protocols.

Verify peptide purity and sequence fidelity first. Request third-party HPLC and mass spec results from your supplier if not provided at purchase. A peptide with 95% HPLC purity but undetected deletion mutations at the WKD motif (positions 12–14) has zero p53-competitive binding and won't induce apoptosis in senescent cells regardless of concentration. If mass spec confirms correct molecular weight and your assay still fails, check reconstitution method: FOXO4-DRI in plain PBS degrades 25–35% within 48 hours at 4°C due to peptide bond hydrolysis. Switch to 10% DMSO or add 0.1% BSA as a stabiliser. Our team has seen this exact scenario three times in the past year. Each time, the peptide was structurally intact but stored incorrectly post-reconstitution.

Calculate cost-per-active-milligram by multiplying advertised price by verified purity and biological activity factor. A peptide advertised at 98% purity but testing at 94% with 25% reduced biological activity costs more per functional dose than a 99%+ verified peptide at 15% higher initial price. Real Peptides AHK-Cu at higher unit cost delivers lower cost-per-experiment when dose adjustments and research time lost to low-quality batches are factored. Budget-driven decisions should compare total research expenditure across a project timeline, not unit pricing in isolation.